Journal of Experimental & Clinical Cancer Research · 2019 · 48 citations · 25 references
MedicineOncologyPharmacologyApoptosisMolecular OncologyProteomicsApoptosis In CancerApoptosis ResistanceCancer ProteomicsCell Cycle SignalingCell-cycle DysregulationMitotic InhibitorsAnticancer ActivityAnticancer Mechanism Of ActionCancer Cell ApoptosisCancer Cell Proliferation InhibitionCell Cycle InhibitionChromosome AlignmentTaxane ResistanceTherapeutic Resistance Mechanisms
BACKGROUND: The deubiquitinase USP7 has been identified as an oncogene with key roles in tumorigenesis and therapeutic resistance for a series of cancer types. Recently small molecular inhibitors have been developed to target USP7. However, the anticancer mechanism of USP7 inhibitors is still elusive. METHODS: Cell viability or clonogenicity was tested by violet crystal assay. Cell apoptosis or cell cycle was analyzed by flow cytometry, and chromosome misalignment was observed by a fluorescent microscopy. The protein interaction of PLK1 and USP7 was detected by tandem affinity purification and high throughput proteomics, and further confirmed by co-immunoprecipitation, GST pull-down and protein co-localization. The correlation between USP7 level of tumor tissues and taxane-resistance was evaluated. RESULTS: Pharmacological USP7 inhibition by P5091 retarded cell proliferation and induced cell apoptosis. Further studies showed that P5091 induced cell cycle arrest at G2/M phase, and particularly induced chromosome misalignment, indicating the key roles of USP7 in mitosis. USP7 protein was detected in the PLK1-interacted protein complex. USP7 interacts with PLK1 protein through its PBD domain by catalytic activity. USP7 as a deubiquitinase sustained PLK1 protein stability via the C223 site, and inversely, USP7 inhibition by P5091 promoted the protein degradation of PLK1 through the ubiquitination-proteasome pathway. By overexpressing PLK1, USP7 that had been depleted by RNAi ceased to induce chromosome misalignment in mitosis and again supported cell proliferation and cell survival. Both USP7 and PLK1 were overexpressed in taxane-resistant cancer cells, and negatively correlated with the MP scores in tumor tissues. Either USP7 or PLK1 knockdown by RNAi significantly sensitized taxane-resistant cells to taxane cell killing. CONCLUSION: This is the first report that PLK1 is a novel substrate of USP7 deubiquitinase, and that USP7 sustained the protein stability of PLK1. USP7 inhibition induces cell apoptosis and cell cycle G2/M arrest, and overcomes taxane resistance by inducing the protein degradation of PLK1, resulting in chromosome misalignment in mitosis.
25
PLK1 Activation in Late G2 Sets Up Commitment to Mitosis
Lilia Gheghiani, Damarys Loew, Bérangère Lombard et al. · Cell Reports · 2017 · 217 citations · Full text
HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma
Omid Tavana, Dawei Li, Chao Dai et al. · Nature Medicine · 2016 · 202 citations
Inactivation of HAUSP in vivo modulates p53 function
Ning Kon, Y. Kobayashi, M Li et al. · Oncogene · 2009 · 176 citations · Full text